Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
The aim is to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)
Subscribe To Our Newsletter & Stay Updated
